Mike's Blog

Tuesday evening, March 25, the US Senate, in a strict party-line vote, confirmed Jay Bhattacharya as the NIH Director. For those googling Jay, be forewarned that while Battacharya is not in the same league as Smith or Jones, a PubMed search on just the last name will yield >17K citations....

There’s been quite a bit of confusion (as well as misinformation) regarding the current status and future of N3C. We’d like to offer some enlightenment.

When the National COVID Cohort Collaborative (N3C) was established in April 2020, its mission was clear: harness the power of harmonized, real-world data incarcerated within disparate...

It’s hard to believe we’re now a quarter of the way through the 21st century!

I’m writing this blog during the week before Christmas. As such, I can’t predict how the new year will start, nor exactly how the old one may end. At the moment, the CR we’re operating currently...

While academic medical centers may be the source for next generation health care interventions and solutions, dissemination and implementation (D&I) of those interventions require a health care infrastructure that can efficiently absorb and deploy those interventions in a manner that can offer patients the opportunity to reap the benefits of...

Last month I highlighted a myriad of initiatives and other efforts concerning drug prices. Some of these efforts are focused on the most upstream and earliest phases of drug development, emphasizing future licensing deals that include language concerning accessibility clauses. Recently, attention has also focused on a major downstream component...